<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: “Treatment of Acute Lymphoblastic Leukemia, T-Cell Lymphoma, and Non-Small Cell Lung Cancer Using the 4A10 Antibody and Fragments Thereof”</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: “Treatment of Acute Lymphoblastic Leukemia, T-Cell Lymphoma, and Non-Small Cell Lung Cancer Using the 4A10 Antibody and Fragments Thereof”</h1>
    <p class="timestamp">Published: 2019-02-15 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patent Applications listed in the Supplementary Information section of this notice to Fannin Partners L.L.C., ("Fannin") of Houston, Texas.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2019-02442</p>
    <p><strong>Publication Date:</strong> 2019-02-15</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/02/15/2019-02442/prospective-grant-of-an-exclusive-patent-license-treatment-of-acute-lymphoblastic-leukemia-t-cell">https://www.federalregister.gov/documents/2019/02/15/2019-02442/prospective-grant-of-an-exclusive-patent-license-treatment-of-acute-lymphoblastic-leukemia-t-cell</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-02442</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
